Samantha G. Pattenden, Ph.D. - Publications

Affiliations: 
2003 University of Toronto, Toronto, ON, Canada 
Area:
Molecular Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vital T, Wali A, Butler KV, Xiong Y, Foster JP, Marcel SS, McFadden AW, Nguyen VU, Bailey BM, Lamb KN, James LI, Frye SV, Mosely AL, Jin J, Pattenden SG, et al. MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicing. Frontiers in Oncology. 13: 1099550. PMID 36793594 DOI: 10.3389/fonc.2023.1099550  0.348
2021 Marcel SS, Quimby AL, Noel MP, Jaimes OC, Mehrab-Mohseni M, Ashur SA, Velasco B, Tsuruta JK, Kasoji SK, Santos CM, Dayton PA, Parker JS, Davis IJ, Pattenden SG. Genome-wide cancer-specific chromatin accessibility patterns derived from archival processed xenograft tumors. Genome Research. PMID 34815311 DOI: 10.1101/gr.275219.121  0.319
2020 Goulet DR, Foster JP, Zawistowski JS, Bevill SM, Noel MP, Olivares-Quintero JF, Sciaky N, Singh D, Santos C, Pattenden SG, Davis IJ, Johnson GL. Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer. Molecular Cancer Research : McR. PMID 32753473 DOI: 10.1158/1541-7786.Mcr-19-1011  0.347
2019 Laurie SJ, Bruce DW, Bommiasamy H, Noel MP, Foster JP, Davis IJ, Pattenden SG, Serody JS. Epigenetic Plasticity of Type II Innate Lymphoid Cells in the Lower Gastrointestinal Tract Blood. 134: 1921-1921. DOI: 10.1182/Blood-2019-126823  0.374
2018 Hopcraft SE, Pattenden SG, James LI, Frye S, Dittmer DP, Damania B. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. Plos Pathogens. 14: e1007267. PMID 30212584 DOI: 10.1371/Journal.Ppat.1007267  0.413
2016 Pattenden SG, Simon JM, Wali A, Jayakody CN, Troutman J, McFadden AW, Wooten J, Wood CC, Frye SV, Janzen WP, Davis IJ. High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibility. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929321 DOI: 10.1073/pnas.1521827113  0.36
2016 Stuckey JI, Dickson BM, Cheng N, Liu Y, Norris JL, Cholensky SH, Tempel W, Qin S, Huber KG, Sagum C, Black K, Li F, Huang XP, Roth BL, Baughman BM, ... ... Pattenden SG, et al. A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. Nature Chemical Biology. PMID 26807715 DOI: 10.1038/Nchembio.2007  0.337
2015 Xu B, On DM, Ma A, Parton T, Konze KD, Pattenden SG, Allison DF, Cai L, Rockowitz S, Liu S, Liu Y, Li F, Vedadi M, Frye SV, Garcia BA, et al. Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia. Blood. 125: 346-57. PMID 25395428 DOI: 10.1182/Blood-2014-06-581082  0.41
2011 Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA, Wasney GA, Siarheyeva A, Dong A, Tempel W, Wang SC, Chen X, Chau I, ... ... Pattenden SG, et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nature Chemical Biology. 7: 566-74. PMID 21743462 DOI: 10.1038/Nchembio.599  0.302
2010 Pattenden SG, Gogol MM, Workman JL. Features of cryptic promoters and their varied reliance on bromodomain-containing factors. Plos One. 5: e12927. PMID 20886085 DOI: 10.1371/Journal.Pone.0012927  0.464
2007 Li B, Gogol M, Carey M, Pattenden SG, Seidel C, Workman JL. Infrequently transcribed long genes depend on the Set2/Rpd3S pathway for accurate transcription. Genes & Development. 21: 1422-30. PMID 17545470 DOI: 10.1101/Gad.1539307  0.33
2006 Shia WJ, Pattenden SG, Workman JL. Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biology. 7: 217. PMID 16689998 DOI: 10.1186/Gb-2006-7-5-217  0.303
2005 Li B, Pattenden SG, Lee D, Gutiérrez J, Chen J, Seidel C, Gerton J, Workman JL. Preferential occupancy of histone variant H2AZ at inactive promoters influences local histone modifications and chromatin remodeling. Proceedings of the National Academy of Sciences of the United States of America. 102: 18385-90. PMID 16344463 DOI: 10.1073/Pnas.0507975102  0.46
2005 Pattenden SG, Chandy MJ, Gutiérrez JL, Workman JL. Chromatin dynamics rule the genome. Genome Biology. 6: 355. PMID 16277758 DOI: 10.1186/Gb-2005-6-11-355  0.322
2005 Lee D, Ezhkova E, Li B, Pattenden SG, Tansey WP, Workman JL. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell. 123: 423-36. PMID 16269334 DOI: 10.1016/J.Cell.2005.08.015  0.507
2005 Ni Z, Karaskov E, Yu T, Callaghan SM, Der S, Park DS, Xu Z, Pattenden SG, Bremner R. Apical role for BRG1 in cytokine-induced promoter assembly. Proceedings of the National Academy of Sciences of the United States of America. 102: 14611-6. PMID 16195385 DOI: 10.1073/Pnas.0503070102  0.501
2002 Pattenden SG, Klose R, Karaskov E, Bremner R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. The Embo Journal. 21: 1978-86. PMID 11953317 DOI: 10.1093/Emboj/21.8.1978  0.448
Show low-probability matches.